Loss-of-function mutations in components of the ATM-mediated DNA damage response such as ATM, MRE11, and H2AX in tandem with overexpression of phosphatase Wip1, a negative regulator of this pathway, contribute to chemoresistance to crosslinking agents in head and neck carcinomas [71]. This evidence concerns the gene ATM and head and neck carcinoma.